These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 6871482)

  • 1. Heterogeneity of estrogen binding sites in mammary tumors.
    Clark JH; Watson CS; Markaverich BM; Syne JS; Panko WB
    Breast Cancer Res Treat; 1983; 3(1):61-5. PubMed ID: 6871482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An endogenous inhibitor of [3H]estradiol binding to nuclear type II estrogen binding sites in normal and malignant tissues.
    Markaverich BM; Roberts RR; Alejandro MA; Clark JH
    Cancer Res; 1984 Apr; 44(4):1515-9. PubMed ID: 6704964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneity of estrogen binding sites in mouse mammary cancer.
    Watson CS; Clark JH
    J Recept Res; 1980; 1(1):91-111. PubMed ID: 7299733
    [No Abstract]   [Full Text] [Related]  

  • 4. Nuclear translocation of the estrogen receptor in autonomous C3H mouse mammary tumors.
    Vignon F; Rochefort H
    Cancer Res; 1978 Jun; 38(6):1808-14. PubMed ID: 647690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of plasma estrogen sulfates in mammary cancer cells.
    Vignon F; Terqui M; Westley B; Derocq D; Rochefort H
    Endocrinology; 1980 Apr; 106(4):1079-86. PubMed ID: 6244140
    [No Abstract]   [Full Text] [Related]  

  • 6. Estradiol binding to nuclear receptors in human breast cancer tissue (MCF-7 cell line) and in dimethylbenz(a)anthracene-induced mammary carcinoma.
    Geier A; Cocos M; Ginzburg R; Haimsohn M; Lunenfeld B
    J Clin Endocrinol Metab; 1979 Jul; 49(1):34-9. PubMed ID: 109464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluctuations in levels of cytosol and nuclear estrogen receptors in rat mammary tumors during the estrous cycle.
    Shih A; Lee C
    Endocrinology; 1978 Feb; 102(2):420-5. PubMed ID: 570481
    [No Abstract]   [Full Text] [Related]  

  • 8. Characterization of progesterone receptors, estrogen receptors, and estrogen (type II)-binding sites in the hormone-independent variant of the MXT-3590 mouse mammary tumor.
    Watson CS; Medina D; Clark JH
    Endocrinology; 1980 Nov; 107(5):1432-7. PubMed ID: 7428677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear translocation and interactions of the estrogen receptor in uterus and mammary tumors.
    Rochefort H; André J; Baskevitch PP; Kallos J; Vignon F; Westley B
    J Steroid Biochem; 1980 Jan; 12():135-42. PubMed ID: 7421202
    [No Abstract]   [Full Text] [Related]  

  • 10. Methyl p-hydroxyphenyllactate and nuclear type II binding sites in malignant cells: metabolic fate and mammary tumor growth.
    Markaverich BM; Gregory RR; Alejandro M; Kittrell FS; Medina D; Clark JH; Varma M; Varma RS
    Cancer Res; 1990 Mar; 50(5):1470-8. PubMed ID: 2302712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear type II sites and malignant cell proliferation: inhibition by 2,6-bis-benzylidenecyclohexanones.
    Markaverich BM; Schauweker TH; Gregory RR; Varma M; Kittrell FS; Medina D; Varma RS
    Cancer Res; 1992 May; 52(9):2482-8. PubMed ID: 1568218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of catechol estrogens to the estrogen receptor of dimethylbenz(A) anthracene induced rat mammary tumors.
    Abul-Hajj YJ
    J Steroid Biochem; 1980 Jan; 13(1):83-8. PubMed ID: 6770198
    [No Abstract]   [Full Text] [Related]  

  • 13. A simple modification of the estrogen receptor exchange assay: validation in nuclei from the rat uterus and a mouse mammary tumor.
    Schoenberg DR; Clark JH
    Endocrinology; 1980 Jan; 106(1):56-60. PubMed ID: 7349972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inter-site variation of oestrogen receptors in human breast cancers.
    Tilley WD; Keightley DD; Cant EL
    Br J Cancer; 1978 Oct; 38(4):544-6. PubMed ID: 728342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of malignant breast tumors containing estrogen receptors].
    El'tsina NV
    Vopr Onkol; 1982; 28(4):95-102. PubMed ID: 7046238
    [No Abstract]   [Full Text] [Related]  

  • 16. Nuclear uptake of oestradiol-17 beta in human mammary tumour tissue.
    Thorsen T; Stoa KF
    J Steroid Biochem; 1979 Jun; 10(6):595-9. PubMed ID: 470382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear binding of the estrogen receptor: heterogeneity of sites and uterotropic response.
    Clark JH; Markaverich B; Upchurch S; Eriksson H; Hardin JW
    Adv Exp Med Biol; 1979; 117():17-46. PubMed ID: 474276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An improved assay for nuclear estrogen receptor in experimental and human breast cancer.
    Garola RE; McGuire WL
    Cancer Res; 1977 Sep; 37(9):3333-7. PubMed ID: 884677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphorylation and estradiol binding of estrogen receptor in hormone-dependent and hormone-independent GR mouse mammary tumors.
    Migliaccio A; Pagano M; De Goeij CC; Di Domenico M; Castoria G; Sluyser M; Auricchio F
    Int J Cancer; 1992 Jul; 51(5):733-9. PubMed ID: 1612782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormone dependence in breast cancer.
    McGuire WL; Chamness GC; Costlow ME; Shepherd RE
    Metabolism; 1974 Jan; 23(1):75-100. PubMed ID: 4357247
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.